יותר ויותר חברות ישראליות שנסחרות בבורסה לניירות ערך בתל-אביב בוחנות את האפשרות להירשם למסחר בארה"ב, בדגש על נאסד"ק, באמצעות American Depositary Receipts או ADRs. במיוחד ניכרת מגמה שכזו בקרב חברות בתחום הביו-מד הישראליות.
Attorneys Oded Har Even, Howard Berkenblit and David Huberman represented RADCOM Ltd. In an underwritten public offering of approximately $23 million. ZAG-S&W handled the transaction in its entire legal and business aspects.
May, 2016
.jpg "The firm represented Mazor Robotics Ltd., in a strategic and complex equity investment by Medtronic")
Attornyes Oded Har-Even, Howard Berkenblit, Rob Condon and David Huberman represented the company. Mazor Robotics Ltd. is traded on the TASE and NASDAQ.
May, 2016
.jpg "Attorneys Oded Har-Even, David Huberman and Robert Condon represented Nano Dimension Ltd.")
Nano Dimension Ltd. (NNDM), a leader in the area of 3D printed electronics, uplisted its American Depositary Shares (ADSs) to the NASDAQ Capital Market under the symbol “NNDM,” effective on March 7, 2016. Nano Dimension’s ordinary shares also trade on the Tel Aviv Stock Exchange.
March, 2016
.jpg "IATI’s forum of public biomed companies")
Adv. Oded Har-Even (third from the right), the managing partner of the firm’s U.S. offices, participated in a meeting of executives from public biomed companies. The participants discussed ways to increase investment by Israeli institutional bodies – banks, insurance companies and private investors, in biomed companies.
Globes, July 21, 2016
A ZAG-S&W Team represented Cellect Biotechnology Ltd. in its initial public offering in the United States of 1,292,308 American Depository Shares (ADSs) and warrants to purchase up to 969,231 ADSs.
The gross proceeds to Cellect from this offering are $8.4 million.
July, 2016
On 9.11.2016 we held a conference together with ACC Israel. Adv. Andrew Solomon, a partner in the litigation department in our offices in New York, Oded Har-Even, director of the US offices and Shay Baranov, director of the international department at our offices in Tel Aviv, Lectured about the various issues faced by companies seeking to expand their operations in the U.S.
.jpg "The firm represented the US investment bank Gunner & Joseph in a public offering of Rennova Health.")
Attorneys Oded Har-Even, Rob Condon, Hila Nahum, Jene Schlack and Ron Ben-Bassat, represented Gunner & Joseph who served as an underwriter in the offering.
July, 2016
ZAG-S&W and Oded Har-Even were featured in the article which discusses two U.S. law firms, including ZAG-S&W, that work extensively with Israeli companies
LAW.COM, 10.10.16
.jpg "ZAG-S&W Team represented DarioHealth Corp. in a private placement on Nasdaq, in an aggregate price of $5.1 million")
Attornyes Oded Har-Even, Ron Ben-Bassat and Robert Condon represented DarioHealth Corp. in the private placement.
The deal was led by OurCrowd Qure, a dedicated digital health fund.
January, 2017
Advs. Oded Har-Even, Rob Condon and Ron Ben-Bassat from the American Capital Markets departmemt at the firm represented the company in a private placement on Nasdaq
Globes, 15.1.2017
Attorneys Oded Har-Even and Howard Berkenbilt from our U.S. Capital Markets department, represented the company in it's acquisition by Francisco Partners L.P in an amount of $438 million.
May, 2015
Attorneys Oded Har-Even, Shy Baranov, Rob Condon, David Huberman and Ron Ben-Bassat, represented Renshaw & Rodman.
June, 2016
Attorneys Oded Har-Even, Howard Berkenblit, Rob Condon and Ron Ben Bassat represented the company.
July, 2016
.jpg "ZAG-S&W Team represented Nano Dimension Ltd. in its public offering of approximately $13.8 million")
The ZAG-S&W team included Oded Har-Even, Howard Berkenblit, Rob Condon, Shy Baranov, David Huberman, Ron Ben-Bassat and Hila Nahum.
September, 2016
.jpg "ZAG-S&W represented Aegis Capital Corp. as Lead Placement Agent in a private placement offering of Rosetta Genomics")
Attornyes Oded Har-Even, Shy Baranov, Rob Condon, Ron Ben-Bassat and Hila Nahum represented Aegis Capital Corp. as Lead Placement Agent in an approximately $5 million concurrent registered direct and private placement offering of ordinary shares, debentures and warrants by Rosetta Genomics, which develops and commercializes a full range of microRNA-based and other molecular diagnostics.
December, 2016
.jpg "ZAG-S&W represented Aegis Capital Corp. as Lead Placement Agent in a private placement offering of Rennova Health Inc.")
Attornyes Oded Har-Even, Shy Baranov, Rob Condon, Ron Ben-Bassat and Hila Nahum represented Aegis Capital Corp. as Lead Placement Agent in an approximately $12.4 million private placement offering of preferred shares By Rennova Health Inc.
December, 2016
.jpg "ZAG-S&W represented Roth Capital as Underwriter in $8.2 million offering of Light Path Technologies Inc.")
Attornyes Oded Har-Even, Rob Condon and Hila Nahum represented Roth Capital.
December, 2016
.jpg "ZAG-S&W represented Roth Capital as underwriter in Top Image System private placecment")
Attorney Oded Har-Even represented Roth Capital in a $5 million private placement of Top Image System.
December, 2016
Attorrneys Oded Har-Even and Robert Condon at the annual conference.
12.9.2016
